Kobayashi M, Chiba S
Jpn Heart J. 1984 Sep;25(5):755-63. doi: 10.1536/ihj.25.755.
Dopamine, administered at a constant infusion rate of 1-2 micrograms/min into the cannulated sinus node artery of the isolated dog atrium, decreased sinus cycle length (SCL) from 630 +/- 19 to 501 +/- 22 msec (mean +/- SEM, 38 trials in 12 atria). However, on sinoatrial conduction time (SACT) estimated by a constant atrial pacing method, dopamine produced 2 types of response (shortening and lengthening) with sinus tachycardia. In 24 trials in 11 atria, the drug decreased SACT from 86 +/- 8 to 56 +/- 4 msec, and in 14 trials in 6 atria it increased SACT from 67 +/- 7 to 101 +/- 9 msec. In general, the effects of dopamine on SACT were dependent on the control levels of SCL: dopamine caused a reduction of SACT at small levels of SCL and a prolongation at large levels. At a control sinus rate of 120 beats/min, dopamine usually shortened SACT. Dopamine-induced shortening of SACT was blocked by a beta-adrenoceptor blocker, propranolol, and an uptake blocker, imipramine, but not by a dopaminergic inhibitor, sulpiride. Furthermore, dopamine-induced lengthening of SACT tended to be suppressed by propranolol, but not by sulpiride. It is concluded that the dopamine-induced changes in SACT are mediated via beta-adrenergic mechanism and partially due to a tyramine-like action.
以1 - 2微克/分钟的恒定输注速率,将多巴胺注入离体犬心房的插管窦房结动脉,窦房结周期长度(SCL)从630±19毫秒降至501±22毫秒(平均值±标准误,12个心房进行了38次试验)。然而,通过恒定心房起搏法估计的窦房传导时间(SACT),多巴胺在窦性心动过速时产生了两种反应(缩短和延长)。在11个心房的24次试验中,该药物使SACT从86±8毫秒降至56±4毫秒,在6个心房的14次试验中,它使SACT从67±7毫秒增至101±9毫秒。一般来说,多巴胺对SACT的影响取决于SCL的对照水平:多巴胺在SCL水平较低时导致SACT缩短,在水平较高时导致延长。在对照窦性心率为120次/分钟时,多巴胺通常会缩短SACT。多巴胺诱导的SACT缩短被β - 肾上腺素能受体阻滞剂普萘洛尔和摄取阻滞剂丙咪嗪阻断,但未被多巴胺能抑制剂舒必利阻断。此外,普萘洛尔倾向于抑制多巴胺诱导的SACT延长,但舒必利则不能。结论是,多巴胺诱导的SACT变化是通过β - 肾上腺素能机制介导的,部分是由于类似酪胺的作用。